ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,947Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 336

$916K Total Retail Price of All Prescriptions

Rank: 51 out of 336

491 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 491 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

33% of this provider’s 491 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

5% of this provider’s 9,009 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 1,076 504 S3 1 2
AMLODIPINE BESYLATE 484 336 2 1
FUROSEMIDE 362 222 3 4
OMEPRAZOLE 338 252 4 3
GLIMEPIRIDE 305 182 5 29
GABAPENTIN 286 173 6 11
PANTOPRAZOLE SODIUM 274 122 7 40
DIOVAN 253 136 8 31
CARVEDILOL 248 137 9 13
METFORMIN HCL 235 142 10 8
LISINOPRIL 231 159 11 6
JANUVIA 227 156 12 67
CARISOPRODOL 212 51 R 13 63
SIMVASTATIN 211 122 14 5
ATORVASTATIN CALCIUM 188 152 15 14
POTASSIUM CHLORIDE 184 107 16 9
LEVOTHYROXINE SODIUM 176 136 17 7
CLONIDINE HCL 168 117 18 32
LOSARTAN POTASSIUM 166 139 19 22
NEXIUM 162 100 20 24
METOPROLOL SUCCINATE 160 136 21 15
VERAPAMIL ER 158 103 22 95
FELODIPINE ER 141 80 23 171
PRAVASTATIN SODIUM 140 98 24 10
MELOXICAM 133 73 25 19
SPIRONOLACTONE-HCTZ 131 88 26 211
DIOVAN HCT 129 77 27 41
GUANFACINE HCL 126 82 R 28 206
CYCLOBENZAPRINE HCL 125 68 R 29 65
ZOLPIDEM TARTRATE 124 67 30 18
HYDROCHLOROTHIAZIDE 122 95 31 12
CLOPIDOGREL 119 106 32 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 34 33 23
ENALAPRIL MALEATE 112 70 34 60
ALLOPURINOL 111 98 35 30
LYRICA 108 49 36 70
AMLODIPINE BESYLATE-BENAZEPRIL 107 79 37 47
TRAMADOL HCL 104 71 38 20
VENTOLIN HFA 103 51 39 130
DOXYCYCLINE HYCLATE 96 50 40 92
CLOTRIMAZOLE-BETAMETHASONE 91 54 41 146
LANTUS 90 31 42 56
DONEPEZIL HCL 89 86 43 27
GLYBURIDE-METFORMIN HCL 89 44 R 43 78
CITALOPRAM HBR 88 50 45 21
ISOSORBIDE MONONITRATE ER 87 66 46 44
METOPROLOL TARTRATE 83 59 47 16
FLUTICASONE PROPIONATE 80 24 48 49
SERTRALINE HCL 79 43 49 33
PLAVIX 76 66 50 37
EXFORGE 75 47 51 121
RANITIDINE HCL 75 39 51 36
SPIRONOLACTONE 70 25 53 42
FAMOTIDINE 69 41 54 73
BENICAR 69 28 54 112
AMITRIPTYLINE HCL 69 43 R 54 57
ATENOLOL 68 28 57 26
OXYBUTYNIN CHLORIDE ER 68 46 57 186
SYMBICORT 68 58 57 155
CRESTOR 68 44 57 25
TRIAMTERENE-HCTZ 67 51 61 35
TIZANIDINE HCL 67 11 61 83
HYDRALAZINE HCL 66 55 63 53
NAMENDA 66 62 63 39
COLCRYS 61 34 65 103
TAMSULOSIN HCL 61 59 65 38
GLIPIZIDE 61 52 65 71
AZITHROMYCIN 60 26 68 58
WARFARIN SODIUM 58 30 69 17
INSULIN SYRINGE 58 12 69 102
PROMETHAZINE HCL 57 18 R 71 99
SINGULAIR 57 30 71 85
ESCITALOPRAM OXALATE 57 38 71 69
SPIRIVA 56 40 74 88
METFORMIN HCL ER 56 25 74 61
PREMARIN 56 19 R 74 131
FLUCONAZOLE 55 24 77 151
COMBIVENT 54 41 78 152
OXYBUTYNIN CHLORIDE 53 41 79 153
AMIODARONE HCL 53 33 79 117
MORPHINE SULFATE ER 52 28 S2 81 182
TRAZODONE HCL 51 30 82 46
SYNTHROID 50 31 83 43
LOVASTATIN 50 48 83 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.